Journal: Int J Biol Macromol / Year: 2025 Title: A VLP vaccine platform comprising the core protein of hepatitis B virus with N-terminal antigen capture. Authors: Kaniz Fatema / Joseph S Snowden / Alexander Watson / Lee Sherry / Neil A Ranson / Nicola J Stonehouse / David J Rowlands / Abstract: Nanoparticle presentation systems offer the potential to develop new vaccines rapidly in response to emerging diseases, a public health need that has become increasingly evident in the wake of the ...Nanoparticle presentation systems offer the potential to develop new vaccines rapidly in response to emerging diseases, a public health need that has become increasingly evident in the wake of the COVID-19 pandemic. Previously, we reported a nanoparticle scaffold system termed VelcroVax. This was constructed by insertion of a high affinity SUMO binding protein (Affimer), able to recognise a SUMO peptide tag, into the major immunodominant region of VLPs assembled from a tandem (fused dimer) form of hepatitis B virus (HBV) core protein (HBc). Here we describe an alternative form, termed N-VelcroVax, a VLP vaccine platform assembled from a monomeric HBc protein (N-anti-SUMO Affimer HBc 190) with the Affimer inserted at the N-terminus. In contrast to the tandem form of VelcroVax, N-VelcroVax VLPs were expressed well in E. coli. The VLPs effectively bound SUMO-tagged Junín virus glycoprotein, gp1 as assessed by structural and serological analyses. Cryo-EM characterisation of N-VelcroVax complexed with a SUMO-Junín gp1 showed continuous density attributable to the fused Affimer, in addition to evidence of target antigen capture. Collectively, these data suggest that N-VelcroVax has potential as a versatile next generation vaccine scaffold.
History
Deposition
Jun 30, 2024
Deposition site: PDBE / Processing site: PDBE
Revision 1.0
Feb 26, 2025
Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: EM metadata / Data content type: EM metadata / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Additional map / Part number: 1 / Data content type: Additional map / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Additional map / Part number: 2 / Data content type: Additional map / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Additional map / Part number: 3 / Data content type: Additional map / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Additional map / Part number: 4 / Data content type: Additional map / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Half map / Part number: 1 / Data content type: Half map / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Half map / Part number: 2 / Data content type: Half map / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Image / Data content type: Image / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Mask / Part number: 1 / Data content type: Mask / Provider: repository / Type: Initial release
Revision 1.0
Feb 26, 2025
Data content type: Primary map / Data content type: Primary map / Provider: repository / Type: Initial release
Data content type: EM metadata / Data content type: EM metadata / EM metadata / Group: Database references / Experimental summary / Data content type: EM metadata / EM metadata / Category: citation / em_admin / Data content type: EM metadata / EM metadata / Item: _citation.journal_volume / _em_admin.last_update
#221 - May 2018 Human Papillomavirus and Vaccines similarity (1)
-
Assembly
Deposited unit
A: N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus B: N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus C: N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus
A: N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus B: N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus C: N-VelcroVax HBcAg with SUMO-Affimer inserted at N-terminus
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi